Delirium And Visual Loss After İntravenous OndansetronApplication in a Pediatric Patient: A Case Report

Abstract

Ondansetron is a selective 5-hydroxytryptamine receptor (5HT-3) antagonist caused by cancer treatment and put into clinical practice as an antiemetic for anesthesia-related nausea and vomiting. Delirium is an organic mental disorder that develops in a short period of time and manifests itself with impairments in various cognitive functions, especially consciousness. In this case report, we aimed to present the patient who presented to the another hospital due to vomiting, who received intravenous (IV) ondansetron treatment, followed by blurred consciousness and vision loss, and to draw attention to the side effects
that may occur after ondansetron.